Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716452
2.
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
Immunity
; 48(3): 500-513.e6, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29548671
3.
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
PLoS Pathog
; 19(12): e1011780, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055771
4.
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
J Virol
; 97(2): e0163522, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749076
5.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
; 97(7): e0159622, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395646
6.
HIV-1 infections with multiple founders associate with the development of neutralization breadth.
PLoS Pathog
; 18(3): e1010369, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303045
7.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
8.
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 17(3): e1009386, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651828
9.
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
PLoS Pathog
; 16(9): e1008764, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881968
10.
RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 16(12): e1009101, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290394
11.
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
J Infect Dis
; 216(9): 1080-1090, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968759
12.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
J Infect Dis
; 213(12): 1946-54, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908741
13.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
J Virol
; 89(15): 7478-93, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972551
14.
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.
J Virol
; 88(2): 1125-39, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24198429
15.
Designing a soluble near full-length HIV-1 gp41 trimer.
J Biol Chem
; 288(1): 234-46, 2013 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23184960
16.
High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.
BMC Genomics
; 15: 864, 2014 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283548
17.
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
Retrovirology
; 11: 8, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444350
18.
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.
J Virol
; 87(14): 7828-36, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658446
19.
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Front Immunol
; 15: 1339727, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38420129
20.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Nat Commun
; 15(1): 3924, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724518